Cynata Therapeutics (ASX:CYP) — Material Events
ASX:CYP · 11 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Cynata Therapeutics Awaits Pivotal Phase 2 and 3 Trial Results Amid Capital RaiseHigh
Cynata Therapeutics anticipates pivotal trial results in Q2 2026 amid capital raising and sector momentum
30 Apr 2026
·Quarterly Activity Report and Appendix 4C
·85
Cynata Completes Key Phase 2 Milestone in aGvHD Trial, Data Due JuneMedium
Cynata completes primary evaluation period in Phase 2 aGvHD trial; results expected June 2026
30 Mar 2026
·Clinical Trial Update
·85
Cynata Therapeutics Poised for Key Trial Results, Extends Cash Runway to Mid-2026Medium
Cynata Therapeutics nears Phase 3 and Phase 2 trial results, strengthens IP, extends cash runway to mid-2026
29 Jan 2026
·Quarterly Activity Report and Appendix 4C
·85
Cynata Completes Phase 2 Enrolment for Promising aGvHD TherapyMedium
Cynata completes enrolment in Phase 2 trial of CYP-001 for life-threatening aGvHD
15 Dec 2025
·Clinical Trial Update
·85
Cynata Therapeutics Raises A$1.5 Million Placement Ahead of Key Clinical Trial ReadoutsMedium
Cynata Therapeutics Raises A$1.5 Million Placement Ahead of Key Clinical Trial Readouts
4 May 2026
·Capital Raising
·85
EMA Paediatric Committee Endorses Cynata’s CYP-001 Trial Plan for aGvHDMedium
Cynata secures EMA positive opinion for paediatric trial plan of CYP-001 in aGvHD
3 June 2026
·Regulatory Update
·85
Cynata Eyes Pivotal Trial Results and Funding Stability Into Mid-2026Medium
Cynata advances clinical trials with key results due Q2 2026 and secures funding through mid-2026
31 Oct 2025
·Quarterly Activity Report and Appendix 4C
·85
Cynata Wraps Final Patient Visit in Pivotal Osteoarthritis TrialMedium
Cynata Completes Final Patient Visit in Phase 3 Osteoarthritis Trial, Results Expected Q2 2026
24 Nov 2025
·Clinical Trial Update
·80
Cynata Therapeutics Narrows Loss as Key Trials Near Data ReadoutsMedium
Cynata Therapeutics narrows half-year loss, advances clinical trials, extends cash runway to mid-2026
26 Feb 2026
·Appendix 4D Half Year Report
·75
Cynata Therapeutics Resumes Trading After Key Trial Results ReleasedMedium
Cynata Therapeutics trading suspension lifted after clinical trial results announcements
19 June 2026
·Reinstatement to Quotation
·70
Cynata Therapeutics Raises $1.2M at 11% Discount via ATM PlacementMedium
Cynata Therapeutics raises $1.2M via ATM equity raise at 11% discount
23 Jan 2026
·Capital Raising
·50
No articles in this tier for the last 12 months.
Market Mentions
9
- appeared in market wrap coverage
These are market wrap articles where Cynata Therapeutics (ASX:CYP) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 25 (15 June -> 19 June) 2026
20 June 2026
Healthcare Wrap - Week 23 (1 June -> 5 June) 2026
6 June 2026
Healthcare Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Market Wrap - Week 14 (30 Mar -> 3 Apr) 2026
4 Apr 2026